News
1h
JCR Pharmaceuticals and Alexion Achieve Milestone in Collaborative Neurodegenerative Disease Program
JCR announced that is has achieved a key research milestone in one of its collaborative programs with Alexion, AstraZeneca ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback